Development and Validation of an Efficient and Highly Sensitive Enzyme-Linked Immunosorbent Assay for Alemtuzumab Quantification in Human Serum and Plasma-Reference-Cited by-同舟云学术

Development and Validation of an Efficient and Highly Sensitive Enzyme-Linked Immunosorbent Assay for Alemtuzumab Quantification in Human Serum and Plasma

Published:2022-09-23 Issue:1 Volume:45 Page:79-86
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Achini-Gutzwiller Federica R.,Jol-van der Zijde Cornelia M.,Jansen-Hoogendijk Anja M.,Lankester Arjan C.,Bredius Robbert G. M.,van Tol Maarten J. D.,Moes Dirk Jan A. R.,Schilham Marco W.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference24 articles.

1. Reshaping human antibodies for therapy;Riechmann;Nature,1988

2. CAMPATH: from concept to clinic;Waldmann;Philos Trans R Soc Lond B Biol Sci.,2005

3. Peripheral blood but not tissue dendritic cells express CD52 and are depleted by treatment with alemtuzumab;Buggins;Blood,2002

4. The CD52 antigen and development of the CAMPATH antibodies;Hale;Cytotherapy,2001

5. Multiple sclerosis: reprogramming the immune repertoire with alemtuzumab in MS;Wiendl;Nat Rev Neurol.,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential for therapeutic drug monitoring of belatacept and other biologicals in solid organ transplantation;British Journal of Clinical Pharmacology;2024-07-26

2. Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study;Blood Advances;2023-08-11

3. Population pharmacokinetics of subcutaneous alemtuzumab in kidney transplantation;British Journal of Clinical Pharmacology;2022-12-09